-
1
-
-
24944531701
-
Inhibition of factor Xa: A potential target for the development of new anticoagulants
-
Alexander JH, Singh KP. Inhibition of factor Xa: a potential target for the development of new anticoagulants. Am J Cardiovasc Drug 2005; 5 (5): 279-90
-
(2005)
Am J Cardiovasc Drug
, vol.5
, Issue.5
, pp. 279-290
-
-
Alexander, J.H.1
Singh, K.P.2
-
2
-
-
25444502110
-
Chronic venous disease and the leukocyte endothelium interaction: From symptoms to ulceration
-
Nicolaides AN. Chronic venous disease and the leukocyte endothelium interaction: from symptoms to ulceration. Angiology 2005; 56 Suppl. 1: S11-9
-
(2005)
Angiology
, vol.56
, Issue.SUPPL. 1
-
-
Nicolaides, A.N.1
-
3
-
-
3142720666
-
Treatment of deep-vein thrombosis
-
Jul 15;
-
Bates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med 2004 Jul 15; 351 (3): 268-77
-
(2004)
N Engl J Med
, vol.351
, Issue.3
, pp. 268-277
-
-
Bates, S.M.1
Ginsberg, J.S.2
-
4
-
-
0038380256
-
The epidemiology of venous thromboembolism
-
White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-8
-
(2003)
Circulation
, vol.107
-
-
White, R.H.1
-
5
-
-
4644288189
-
-
Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Anti- thrombotic and Thrombolytic Therapy. Chest 2004 Sep; 126 (3 Suppl.): 338-400S
-
Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Anti- thrombotic and Thrombolytic Therapy. Chest 2004 Sep; 126 (3 Suppl.): 338-400S
-
-
-
-
6
-
-
37249019232
-
-
MedlinePlus Medical Encyclopedia. Unstable angina [online]. Available from URL: http://www.nlm.nih.gov/medlineplus/ency/article/000201.htm [Accessed 2006 Nov 23]
-
MedlinePlus Medical Encyclopedia. Unstable angina [online]. Available from URL: http://www.nlm.nih.gov/medlineplus/ency/article/000201.htm [Accessed 2006 Nov 23]
-
-
-
-
7
-
-
0031933561
-
Low-molecular-weight heparins for acute coronary syndromes
-
Spinler SA, Nawarskas JJ. Low-molecular-weight heparins for acute coronary syndromes. Ann Pharmacother 1998; 32 (1): 103-10
-
(1998)
Ann Pharmacother
, vol.32
, Issue.1
, pp. 103-110
-
-
Spinler, S.A.1
Nawarskas, J.J.2
-
8
-
-
0021962018
-
The prevalence of peripheral arterial disease in a defined population
-
Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71 (3): 510-5
-
(1985)
Circulation
, vol.71
, Issue.3
, pp. 510-515
-
-
Criqui, M.H.1
Fronek, A.2
Barrett-Connor, E.3
-
9
-
-
0028890284
-
Parnaparin: A review of its pharmacological profile and clinical application
-
Dettori AG. Parnaparin: a review of its pharmacological profile and clinical application. Drugs Today 1995; 31 (1): 19-35
-
(1995)
Drugs Today
, vol.31
, Issue.1
, pp. 19-35
-
-
Dettori, A.G.1
-
10
-
-
0031731396
-
The use of low-molecular-weight heparins in cardiovascular disease
-
Verhaeghe R. The use of low-molecular-weight heparins in cardiovascular disease. Acta Cardiol 1998; 53 (1): 15-21
-
(1998)
Acta Cardiol
, vol.53
, Issue.1
, pp. 15-21
-
-
Verhaeghe, R.1
-
11
-
-
0033817335
-
Comparative pharmacokinetics of LMWHs
-
Samama MM, Gerotziafas GT. Comparative pharmacokinetics of LMWHs. Semin Thromb Hemost 2000; 26 (3 Suppl. 1): 31-8
-
(2000)
Semin Thromb Hemost
, vol.26
, Issue.3 SUPPL. 1
, pp. 31-38
-
-
Samama, M.M.1
Gerotziafas, G.T.2
-
12
-
-
11144352753
-
Generic low-molecular-weight heparins: Some practical considerations
-
Dec;
-
Fareed J, Leong WL, Hoppensteadt DA, et al. Generic low-molecular-weight heparins: some practical considerations. Semin Thromb Hemost 2004 Dec; 30 (6): 703-13
-
(2004)
Semin Thromb Hemost
, vol.30
, Issue.6
, pp. 703-713
-
-
Fareed, J.1
Leong, W.L.2
Hoppensteadt, D.A.3
-
13
-
-
0028349245
-
Parnaparin: A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders
-
Apr;
-
Frampton JE, Faulds D. Parnaparin: a review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders. Drugs 1994 Apr; 47: 652-76
-
(1994)
Drugs
, vol.47
, pp. 652-676
-
-
Frampton, J.E.1
Faulds, D.2
-
14
-
-
37249005458
-
-
Fluxum™: summary of product characteristics. Bologna: Alfa Wassermann, 2007
-
Fluxum™: summary of product characteristics. Bologna: Alfa Wassermann, 2007
-
-
-
-
15
-
-
21244480057
-
Prevention of platelet-polymorphonuclear leukocyte interactions: New clues to the antithrombotic properties of parnaparin, a low molecular weight heparin
-
Jun;
-
Maugeri N, de Gaetano G, Barbanti M, et al. Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin. Haematologica 2005 Jun; 90 (6): 833-9
-
(2005)
Haematologica
, vol.90
, Issue.6
, pp. 833-839
-
-
Maugeri, N.1
de Gaetano, G.2
Barbanti, M.3
-
16
-
-
34250634775
-
Parnaparin, a low-molecular-weight heparin, prevents P-select-independent formation of platelet-leukocyte aggregates in human whole blood
-
Jun;
-
Maugeri N, Di Fabio G, Barbanti M, et al. Parnaparin, a low-molecular-weight heparin, prevents P-select-independent formation of platelet-leukocyte aggregates in human whole blood. Thromb Haemost 2007 Jun; 97 (6): 965-73
-
(2007)
Thromb Haemost
, vol.97
, Issue.6
, pp. 965-973
-
-
Maugeri, N.1
Di Fabio, G.2
Barbanti, M.3
-
17
-
-
0027213684
-
Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects
-
Melandri G, Semprini F, Cervi V, et al. Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects. Am J Cardiol 1993; 72: 450-4
-
(1993)
Am J Cardiol
, vol.72
, pp. 450-454
-
-
Melandri, G.1
Semprini, F.2
Cervi, V.3
-
18
-
-
23044467243
-
Differential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins: Pharmacologic implications
-
Dec;
-
Florian-Kujawski M, Hoppensteadt D, Maddineni J, et al. Differential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins: pharmacologic implications. Int Angiol 2004 Dec; 23 (4): 346-54
-
(2004)
Int Angiol
, vol.23
, Issue.4
, pp. 346-354
-
-
Florian-Kujawski, M.1
Hoppensteadt, D.2
Maddineni, J.3
-
19
-
-
0024337044
-
Pharmacodynamic effects on blood coagulation of a new low molecular weight heparin (alfa-LMWH) in healthy volunteers and gynecological surgery patients
-
Jan;
-
Palareti G, Legnani C, Bianchini B, et al. Pharmacodynamic effects on blood coagulation of a new low molecular weight heparin (alfa-LMWH) in healthy volunteers and gynecological surgery patients. Int Angiol 1989 Jan; 8 (1): 47-52
-
(1989)
Int Angiol
, vol.8
, Issue.1
, pp. 47-52
-
-
Palareti, G.1
Legnani, C.2
Bianchini, B.3
-
20
-
-
0023816509
-
Clinical pharmacology of a new low molecular weight heparin (alfa LMWH-Fluxum)
-
Jul;
-
Dettori AG, Tagliaferri A, Dall'Aglio E, et al. Clinical pharmacology of a new low molecular weight heparin (alfa LMWH-Fluxum). Int Angiol 1988 Jul; 7 (3 Suppl.): 7-18
-
(1988)
Int Angiol
, vol.7
, Issue.3 SUPPL.
, pp. 7-18
-
-
Dettori, A.G.1
Tagliaferri, A.2
Dall'Aglio, E.3
-
21
-
-
0023721636
-
Low molecular weight heparins for long-term therapy of peripheral vascular disease
-
Di Stefano F, Giglio A, Vinci M, et al. Low molecular weight heparins for long-term therapy of peripheral vascular disease. Curr Ther Res 1988; 44 (1): 1-10
-
(1988)
Curr Ther Res
, vol.44
, Issue.1
, pp. 1-10
-
-
Di Stefano, F.1
Giglio, A.2
Vinci, M.3
-
22
-
-
0023489220
-
Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery
-
Speziale F, Verardi S, Taurino M, et al. Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery. Pharmatherapeutica 1988; 5 (4): 261-8
-
(1988)
Pharmatherapeutica
, vol.5
, Issue.4
, pp. 261-268
-
-
Speziale, F.1
Verardi, S.2
Taurino, M.3
-
23
-
-
0026519749
-
Post-surgical deep vein thrombosis prevention: Evaluation of the risk/benefit ratio of fractionated and unfractionated heparin
-
Garcea D, Martuzzi F, Santelmo N, et al. Post-surgical deep vein thrombosis prevention: evaluation of the risk/benefit ratio of fractionated and unfractionated heparin. Curr Med Res Opin 1992; 12 (9): 572-83
-
(1992)
Curr Med Res Opin
, vol.12
, Issue.9
, pp. 572-583
-
-
Garcea, D.1
Martuzzi, F.2
Santelmo, N.3
-
24
-
-
0023772308
-
The use of low molecular weight heparins for post-surgical deep vein thrombosis prevention in orthopaedic patients
-
Chiapuzzo E, Orengo GB, Ottria G, et al. The use of low molecular weight heparins for post-surgical deep vein thrombosis prevention in orthopaedic patients. J Int Med Res 1988; 16: 359-66
-
(1988)
J Int Med Res
, vol.16
, pp. 359-366
-
-
Chiapuzzo, E.1
Orengo, G.B.2
Ottria, G.3
-
25
-
-
37249031102
-
Pharmacodynamic of low molecular weight heparin (LMWH) in obese subjects undergoing bariatric surgery: A prospective randomised study comparing two different doses of parnaparin [abstract no. P153]. Haematologica 2006; 91 Suppl. 2: 89. Plus poster
-
presented at the, Sep 14-17: Milan
-
Legnani C, Imberti D, Cini M, et al. Pharmacodynamic of low molecular weight heparin (LMWH) in obese subjects undergoing bariatric surgery: a prospective randomised study comparing two different doses of parnaparin [abstract no. P153]. Haematologica 2006; 91 Suppl. 2: 89. Plus poster presented at the XIX Congress of the Italian Society for Studies on Hemostasis and Thrombosis; 2006 Sep 14-17: Milan
-
(2006)
XIX Congress of the Italian Society for Studies on Hemostasis and Thrombosis
-
-
Legnani, C.1
Imberti, D.2
Cini, M.3
-
26
-
-
0026762621
-
Effects of two dosages of subcutaneous low molecular weight heparin (parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarction
-
May 1;
-
Melandri G, Branzi A, Semprini F, et al. Effects of two dosages of subcutaneous low molecular weight heparin (parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarction. Thromb Res 1992 May 1; 66 (2-3): 141-50
-
(1992)
Thromb Res
, vol.66
, Issue.2-3
, pp. 141-150
-
-
Melandri, G.1
Branzi, A.2
Semprini, F.3
-
27
-
-
0026033543
-
Efficacy of low-molecular-weight heparin in the management of intermittent claudication
-
Mannarino E, Pasqualini L, Innocente S, et al. Efficacy of low-molecular-weight heparin in the management of intermittent claudication. Angiology 1991; 42 (1): 1-7
-
(1991)
Angiology
, vol.42
, Issue.1
, pp. 1-7
-
-
Mannarino, E.1
Pasqualini, L.2
Innocente, S.3
-
28
-
-
0027446423
-
Clinical assessment of low molecular weight heparin effects in peripheral vascular disease
-
Mar;
-
Calabro A, Piarulli F, Milan D, et al. Clinical assessment of low molecular weight heparin effects in peripheral vascular disease. Angiology 1993 Mar; 44: 188-95
-
(1993)
Angiology
, vol.44
, pp. 188-195
-
-
Calabro, A.1
Piarulli, F.2
Milan, D.3
-
29
-
-
33644671315
-
Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study
-
PRIME CARE Study Investigators Group
-
PRIME CARE Study Investigators Group. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study. Indian Heart J 2005; 57: 648-54
-
(2005)
Indian Heart J
, vol.57
, pp. 648-654
-
-
-
30
-
-
36148996461
-
Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction
-
Wang X-K, Zhang Y, Yang C-M, et al. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction. Clin Drug Invest 2006; 26 (6): 341-9
-
(2006)
Clin Drug Invest
, vol.26
, Issue.6
, pp. 341-349
-
-
Wang, X.-K.1
Zhang, Y.2
Yang, C.-M.3
-
32
-
-
1642477712
-
Low-molecular-weight heparins for the treatment of acute coronary syndromes
-
Wong GC, Giugliano RP. Low-molecular-weight heparins for the treatment of acute coronary syndromes. Semin Vasc Med 2003; 3 (4): 391-402
-
(2003)
Semin Vasc Med
, vol.3
, Issue.4
, pp. 391-402
-
-
Wong, G.C.1
Giugliano, R.P.2
-
33
-
-
0026711157
-
Human pharmacology of a low-molecular-weight heparin (alfa-LMWH): An update
-
Jul;
-
Dettori AG, Babbini M. Human pharmacology of a low-molecular-weight heparin (alfa-LMWH): an update. Med Res Rev 1992 Jul; 12 (4): 373-89
-
(1992)
Med Res Rev
, vol.12
, Issue.4
, pp. 373-389
-
-
Dettori, A.G.1
Babbini, M.2
-
34
-
-
37249034342
-
Influence of the administration site on the bioavailability of a new low molecular weight heparin administered by subcutaneous route. Aggiornamenti di Medicina e
-
Agrati AM, Ambrosi G, Spinelli G, et al. Influence of the administration site on the bioavailability of a new low molecular weight heparin administered by subcutaneous route. Aggiornamenti di Medicina e Chirurgia 1991; 9 (3): 375-9
-
(1991)
Chirurgia
, vol.9
, Issue.3
, pp. 375-379
-
-
Agrati, A.M.1
Ambrosi, G.2
Spinelli, G.3
-
35
-
-
0023682894
-
Kinetic control in healthy volunteers of low molecular weight heparin antithrombotic activity
-
Palmieri GC, Ambrosi G, Ferrero G. Kinetic control in healthy volunteers of low molecular weight heparin antithrombotic activity. Riv Eur Sci Med Farmacol 1988; 10: 187-92
-
(1988)
Riv Eur Sci Med Farmacol
, vol.10
, pp. 187-192
-
-
Palmieri, G.C.1
Ambrosi, G.2
Ferrero, G.3
-
36
-
-
37249016611
-
Pharmacodynamic properties of a new low moleular weight heparin, parnaparin [abstract no. 09]
-
Harenberg J. Pharmacodynamic properties of a new low moleular weight heparin, parnaparin [abstract no. 09]. Thromb Res 1993; 70 Suppl. 1: 162
-
(1993)
Thromb Res
, vol.70
, Issue.SUPPL. 1
, pp. 162
-
-
Harenberg, J.1
-
37
-
-
0023722567
-
Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent postoperative deep venous thrombosis
-
Valle I, Sola G, Origone A. Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent postoperative deep venous thrombosis. Curr Med Res Opin 1988; 11 (2): 80-6
-
(1988)
Curr Med Res Opin
, vol.11
, Issue.2
, pp. 80-86
-
-
Valle, I.1
Sola, G.2
Origone, A.3
-
38
-
-
0024443327
-
Low molecular weight heparin (alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures
-
Jul;
-
Pini M, Tagliaferri A, Manotti C, et al. Low molecular weight heparin (alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures. Int Angiol 1989 Jul; 8 (3): 134-9
-
(1989)
Int Angiol
, vol.8
, Issue.3
, pp. 134-139
-
-
Pini, M.1
Tagliaferri, A.2
Manotti, C.3
-
39
-
-
0027859071
-
Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery
-
Beghi C, Fragnito C, Antonelli A, et al. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery. Int Angiol 1993; 12 (4): 383-6
-
(1993)
Int Angiol
, vol.12
, Issue.4
, pp. 383-386
-
-
Beghi, C.1
Fragnito, C.2
Antonelli, A.3
-
40
-
-
0023709245
-
A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis
-
Jul;
-
Verardi S, Casciani CU, Nicora E, et al. A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis. Int Angiol 1988 Jul; 7 (3 Suppl.): 19-24
-
(1988)
Int Angiol
, vol.7
, Issue.3 SUPPL.
, pp. 19-24
-
-
Verardi, S.1
Casciani, C.U.2
Nicora, E.3
-
41
-
-
0023923994
-
Postsurgery thromboembolism prevention by LMW heparin subcutaneous administration
-
Mascali F, Condorelli A, Salanitiri G, et al. Postsurgery thromboembolism prevention by LMW heparin subcutaneous administration. Eur Rev Med Pharmacol Sci 1988; 10: 135-41
-
(1988)
Eur Rev Med Pharmacol Sci
, vol.10
, pp. 135-141
-
-
Mascali, F.1
Condorelli, A.2
Salanitiri, G.3
-
42
-
-
34347212202
-
Clinical experience with parnaparin in orthopedic surgery
-
Bandiera S, Casalini D, Friemel P, et al. Clinical experience with parnaparin in orthopedic surgery. Euro Bull Drug Res 2003; 11 (4): 77-91
-
(2003)
Euro Bull Drug Res
, vol.11
, Issue.4
, pp. 77-91
-
-
Bandiera, S.1
Casalini, D.2
Friemel, P.3
-
43
-
-
34347223237
-
Prophylaxis of venous thromboembolism in minor orthopedic surgery with parnaparin
-
Montebugnoli M, Bugamelli S, Calo P, et al. Prophylaxis of venous thromboembolism in minor orthopedic surgery with parnaparin. Clin Appl Thromb Hemost 2007; 13 (3): 249-58
-
(2007)
Clin Appl Thromb Hemost
, vol.13
, Issue.3
, pp. 249-258
-
-
Montebugnoli, M.1
Bugamelli, S.2
Calo, P.3
-
44
-
-
0023787086
-
Antithrombotic treatment during acute inflammatory complications of patients affected by postphlebytic syndrome: LMW-heparin versus standard heparin
-
Verardi S, Ippoliti A, Pistolese GR. Antithrombotic treatment during acute inflammatory complications of patients affected by postphlebytic syndrome: LMW-heparin versus standard heparin. Int Angiol 1988; 7 Suppl. 3: 33-40
-
(1988)
Int Angiol
, vol.7
, Issue.SUPPL. 3
, pp. 33-40
-
-
Verardi, S.1
Ippoliti, A.2
Pistolese, G.R.3
-
45
-
-
0024953575
-
Antithrombotic therapy in phlebopathies of lower limbs: A controlled study of low molecular weight heparin versus heparin calcium
-
Luttichau U, Palazzini E. Antithrombotic therapy in phlebopathies of lower limbs: a controlled study of low molecular weight heparin versus heparin calcium. Eur Rev Med Pharmacol Sci 1989; 11: 351-8
-
(1989)
Eur Rev Med Pharmacol Sci
, vol.11
, pp. 351-358
-
-
Luttichau, U.1
Palazzini, E.2
-
46
-
-
0027817086
-
Low molecular weight heparins in chronic venous insufficiency: Controlled trial of parnaparin efficacy and tolerability
-
Della Marchina M, Renzi G, Renzi C, et al. Low molecular weight heparins in chronic venous insufficiency: controlled trial of parnaparin efficacy and tolerability. Br J Clin Res 1993; 4: 29-36
-
(1993)
Br J Clin Res
, vol.4
, pp. 29-36
-
-
Della Marchina, M.1
Renzi, G.2
Renzi, C.3
-
47
-
-
37249006938
-
Medium term treatment of thrombotic pathologies of the lower limbs with a new LMW heparin
-
Mangialardi N, Matteoni R, Serrao E, et al. Medium term treatment of thrombotic pathologies of the lower limbs with a new LMW heparin. Medical Praxis 1991; 12: 1-7
-
(1991)
Medical Praxis
, vol.12
, pp. 1-7
-
-
Mangialardi, N.1
Matteoni, R.2
Serrao, E.3
-
48
-
-
37249051051
-
Heparin therapy of post-phlebitic syndrome: Results of a single-blind, clinical trial of parnaparin vs calcium heparin
-
Catania G, Salanitri T. Heparin therapy of post-phlebitic syndrome: results of a single-blind, clinical trial of parnaparin vs calcium heparin. Stampa Medica Europea 1993; 13: 17-27
-
(1993)
Stampa Medica Europea
, vol.13
, pp. 17-27
-
-
Catania, G.1
Salanitri, T.2
-
49
-
-
0024693905
-
Low molecular weight heparin in the symptomatic treatment of chronic venous insufficiency: Controlled double blind study vs calcium heparin
-
Sannazzari P. Low molecular weight heparin in the symptomatic treatment of chronic venous insufficiency: controlled double blind study vs calcium heparin. Panminerva Med 1989; 31 (3): 127-33
-
(1989)
Panminerva Med
, vol.31
, Issue.3
, pp. 127-133
-
-
Sannazzari, P.1
-
50
-
-
34250712893
-
Home therapy with LMWH in deep vein thrombosis: Randomized study comparing single and double daily administrations
-
Bellosta R, Ferrari P, Luzzani L, et al. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations. Angiology 2007; 58 (3): 316-22
-
(2007)
Angiology
, vol.58
, Issue.3
, pp. 316-322
-
-
Bellosta, R.1
Ferrari, P.2
Luzzani, L.3
-
51
-
-
0027527203
-
Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris: A double-blind, randomized, placebo-controlled trial
-
Melandri G, Semprini F, Cervi V, et al. Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris: a double-blind, randomized, placebo-controlled trial. Circulation 1993; 88: 2517-23
-
(1993)
Circulation
, vol.88
, pp. 2517-2523
-
-
Melandri, G.1
Semprini, F.2
Cervi, V.3
-
52
-
-
0027467042
-
Low molecular weight heparins: Therapeutic insight in peripheral arterial occlusive disease
-
Apr;
-
Simoni G, Lucertini G, Decian F. Low molecular weight heparins: therapeutic insight in peripheral arterial occlusive disease. Clin Trials Metaanal 1993 Apr; 28: 137-45
-
(1993)
Clin Trials Metaanal
, vol.28
, pp. 137-145
-
-
Simoni, G.1
Lucertini, G.2
Decian, F.3
-
53
-
-
0023763318
-
A new low molecular weight heparin in the treatment of peripheral arterial disease
-
Palmieri G, Ambrosi G, Agrati AM, et al. A new low molecular weight heparin in the treatment of peripheral arterial disease. Int Angiol 1988; 7 Suppl. 3: 41-7
-
(1988)
Int Angiol
, vol.7
, Issue.SUPPL. 3
, pp. 41-47
-
-
Palmieri, G.1
Ambrosi, G.2
Agrati, A.M.3
-
54
-
-
27644563148
-
The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: A prospective cohort study
-
Nov 1;
-
Prandoni P, Siragusa S, Girolami B, et al. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study. Blood 2005 Nov 1; 106 (9): 3049-54
-
(2005)
Blood
, vol.106
, Issue.9
, pp. 3049-3054
-
-
Prandoni, P.1
Siragusa, S.2
Girolami, B.3
-
55
-
-
1642298343
-
Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: A literature review
-
Messmore HL, Coyne E, Wehrmacher WH, et al. Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: a literature review. Curr Pharm Des 2004; 10 (9): 1001-10
-
(2004)
Curr Pharm Des
, vol.10
, Issue.9
, pp. 1001-1010
-
-
Messmore, H.L.1
Coyne, E.2
Wehrmacher, W.H.3
-
56
-
-
33644645358
-
Guidelines on the use and monitoring of heparin. The British Committee for Standards in Haematology
-
Baglin T, Barrowcliffe TW, Cohen A, et al. Guidelines on the use and monitoring of heparin. The British Committee for Standards in Haematology. Br J Haematol 2006; 133 (1): 19-34
-
(2006)
Br J Haematol
, vol.133
, Issue.1
, pp. 19-34
-
-
Baglin, T.1
Barrowcliffe, T.W.2
Cohen, A.3
-
57
-
-
2342621534
-
Treatment of venous thromboembolism with low-molecular-weight heparin: A synthesis of the evidence published in systematic literature reviews
-
Krishnan JA, Segal JB, Streiff MB, et al. Treatment of venous thromboembolism with low-molecular-weight heparin: a synthesis of the evidence published in systematic literature reviews. Respir Med 2004; 98 (5): 376-86
-
(2004)
Respir Med
, vol.98
, Issue.5
, pp. 376-386
-
-
Krishnan, J.A.1
Segal, J.B.2
Streiff, M.B.3
-
58
-
-
33644877317
-
Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: A meta-analysis of the randomised trials
-
Eikelboom JW, Quinlan DJ, Mehta SR, et al. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomised trials. Circulation 2005; 112: 3855-67
-
(2005)
Circulation
, vol.112
, pp. 3855-3867
-
-
Eikelboom, J.W.1
Quinlan, D.J.2
Mehta, S.R.3
-
59
-
-
0029035681
-
Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin
-
Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5
-
(1995)
N Engl J Med
, vol.332
, pp. 1330-1335
-
-
Warkentin, T.E.1
Levine, M.N.2
Hirsh, J.3
-
60
-
-
0032925807
-
Low-molecular weight heparins compared with unfractionated heparin for the treatment of acute deep venous thrombosis: A cost-effectiveness analysis
-
Gould MK, Dembitzer AD, Sanders GD, et al. Low-molecular weight heparins compared with unfractionated heparin for the treatment of acute deep venous thrombosis: a cost-effectiveness analysis. Ann Intern Med 1999; 130 (10): 789-99
-
(1999)
Ann Intern Med
, vol.130
, Issue.10
, pp. 789-799
-
-
Gould, M.K.1
Dembitzer, A.D.2
Sanders, G.D.3
-
61
-
-
37249021065
-
Parnaparin: Comparison with other low molecular weight heparins [in Italian]
-
Pradelli L. Parnaparin: comparison with other low molecular weight heparins [in Italian]. Farmeconomia e Percorsi Terapeutici 2005; 6 (3): 227-41
-
(2005)
Farmeconomia e Percorsi Terapeutici
, vol.6
, Issue.3
, pp. 227-241
-
-
Pradelli, L.1
-
62
-
-
24944495296
-
Fondaparinux sodium: A review of its use in the treatment of acute venous thromboembolism
-
Robinson DM, Wellington K. Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism. Am J Cardiovasc Drug 2005; 5 (5): 335-46
-
(2005)
Am J Cardiovasc Drug
, vol.5
, Issue.5
, pp. 335-346
-
-
Robinson, D.M.1
Wellington, K.2
|